GlaxoSmithkline Consumer Healthcare rose 1.59% to Rs 2,720 at 13:57 IST on BSE, with the stock extending Wednesday's 1.46% gains triggered by the company reporting strong Q2 earnings.
Meanwhile, the BSE Sensex was down 64.80 points or 0.38% to 17,192.58.
On BSE, 1,382 shares were traded in the counter as against average daily volume of 7,709 shares over the past one quarter.
The stock hit a high of Rs 2,748 and a low of Rs 2,700 so far during the day. The stock had hit a record high of Rs 2,939.85 on 26 April 2012. The stock had hit a 52-week low of Rs 2,179 on 18 July 2012.
The large-cap stock had underperformed the market over the past one month till 1 August 2012, falling 2.05% compared with the Sensex's 0.99% fall. The scrip had also underperformed the market in past one quarter, declining 4.65% as against Sensex's 0.35% fall.
The company has an equity capital of Rs 42.06 crore. Face value per share is Rs 10.
Shares of GlaxoSmithkline Consumer Healthcare have risen 3.06% in two trading sessions from Rs 2,639 on 31 July 2012, after the company during trading hours on Wednesday, 1 August 2012 reported strong Q2 earnings. The stock had risen 1.46% to settle at Rs 2,677.55 on Wednesday, 1 August 2012.
GlaxoSmithkline Consumer Healthcare's net profit jumped 29.3% to Rs 106.60 crore on 11.7% growth in net sales to Rs 729.73 crore in Q2 June 2012 over Q2 June 2011.
GlaxoSmithkline Consumer Healthcare is leading player in the malted food drinks segment. Some of its major brands include Horlicks, Boost, Viva, and Maltova.
Powered by Capital Market - Live News
